Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

  • Mohamad Mohty*
  • , Florent Malard
  • , Ahmed S. Alaskar
  • , Mahmoud Aljurf
  • , Mutlu Arat
  • , Peter Bader
  • , Frederic Baron
  • , Ali Bazarbachi
  • , Didier Blaise
  • , Eolia Brissot
  • , Fabio Ciceri
  • , Selim Corbacioglu
  • , Jean Hugues Dalle
  • , Fiona Dignan
  • , Anne Huynh
  • , Michelle Kenyon
  • , Arnon Nagler
  • , Antonio Pagliuca
  • , Zinaida Perić
  • , Paul G. Richardson
  • Annalisa Ruggeri, Tapani Ruutu, Ibrahim Yakoub-Agha, Rafael F. Duarte, Enric Carreras
*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

79 Scopus citations

Abstract

Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life-threatening complication that can develop after hematopoietic cell transplantation (HCT). A new definition for diagnosis, and a severity grading system for SOS/VOD in adult patients, was reported a few years ago on behalf of the European Society for Blood and Marrow Transplantation (EBMT). The aim of this work is to update knowledge regarding diagnosis and severity assessment of SOS/VOD in adult patients, and also its pathophysiology and treatment. In particular, we now propose to refine the previous classification and distinguish probable, clinical and proven SOS/VOD at diagnosis. We also provide an accurate definition of multiorgan dysfunction (MOD) for SOS/VOD severity grading based on Sequential Organ Failure Assessment (SOFA) score.

Original languageEnglish
Pages (from-to)749-754
Number of pages6
JournalBone Marrow Transplantation
Volume58
Issue number7
DOIs
StatePublished - Jul 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)'. Together they form a unique fingerprint.

Cite this